[HTML][HTML] Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
M Sommer, LK Nielsen, LB Nielsen… - Health and Quality of …, 2021 - Springer
Background Patients with hematological cancer who experience relapse or progressive
disease often face yet another line of treatment and continued mortality risk that could …
disease often face yet another line of treatment and continued mortality risk that could …
Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
M Sommer, LK Nielsen, LB Nielsen… - Health and Quality …, 2021 - search.proquest.com
Background Patients with hematological cancer who experience relapse or progressive
disease often face yet another line of treatment and continued mortality risk that could …
disease often face yet another line of treatment and continued mortality risk that could …
[HTML][HTML] Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
M Sommer, LK Nielsen, LB Nielsen… - Health and Quality of …, 2021 - vbn.aau.dk
BACKGROUND: Patients with hematological cancer who experience relapse or progressive
disease often face yet another line of treatment and continued mortality risk that could …
disease often face yet another line of treatment and continued mortality risk that could …
Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
M Sommer, LK Nielsen, LB Nielsen… - Health and quality …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Patients with hematological cancer who experience relapse or progressive
disease often face yet another line of treatment and continued mortality risk that could …
disease often face yet another line of treatment and continued mortality risk that could …
Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study.
M Sommer, LK Nielsen, LB Nielsen… - Health and Quality of …, 2021 - go.gale.com
Background Patients with hematological cancer who experience relapse or progressive
disease often face yet another line of treatment and continued mortality risk that could …
disease often face yet another line of treatment and continued mortality risk that could …
Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
M Sommer, LK Nielsen, LB Nielsen… - Health and Quality of …, 2021 - pure.au.dk
Background: Patients with hematological cancer who experience relapse or progressive
disease often face yet another line of treatment and continued mortality risk that could …
disease often face yet another line of treatment and continued mortality risk that could …
[HTML][HTML] Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
M Sommer, LK Nielsen, LB Nielsen… - Health and Quality …, 2021 - hqlo.biomedcentral.com
Patients with hematological cancer who experience relapse or progressive disease often
face yet another line of treatment and continued mortality risk that could increase their …
face yet another line of treatment and continued mortality risk that could increase their …
Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study.
M Sommer, LK Nielsen, LB Nielsen… - Health and Quality of …, 2021 - europepmc.org
Background Patients with hematological cancer who experience relapse or progressive
disease often face yet another line of treatment and continued mortality risk that could …
disease often face yet another line of treatment and continued mortality risk that could …
[HTML][HTML] Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
M Sommer, LK Nielsen, LB Nielsen… - Health and Quality of …, 2021 - ncbi.nlm.nih.gov
Background Patients with hematological cancer who experience relapse or progressive
disease often face yet another line of treatment and continued mortality risk that could …
disease often face yet another line of treatment and continued mortality risk that could …
Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
M Sommer, LK Nielsen, LB Nielsen… - Health and Quality of …, 2021 - ucviden.dk
Background: Patients with hematological cancer who experience relapse or progressive
disease often face yet another line of treatment and continued mortality risk that could …
disease often face yet another line of treatment and continued mortality risk that could …